From: Methodological framework for radiomics applications in Hodgkin’s lymphoma
Non-R/R | R/R | Overall | |
---|---|---|---|
Age, years | |||
Median and range | 46 (19–66) | 33 (24–71) | 35 (19–71) |
Sex | |||
Male | 5 | 15 | 20 |
Female | 3 | 4 | 7 |
Target HL lesions, n | |||
Nodal | 48 | 105 | 153 |
Extra-nodal | 50 | 134 | 184 |
Bone | 46 | 84 | 130 |
Liver | 2 | 5 | 7 |
Lung | – | 19 | 19 |
Spleen | 2 | 24 | 26 |
Other | – | 2 | 2 |
Overall (nodal + extra-nodal) | 98 | 239 | 337 |
Mean lesion number ± standard deviation | 12 ± 9 | 13 ± 11 | 12 ± 10 |
Median lesion number, range | 10 (4–27) | 9 (3–40) | 9 (3–40) |